Literature DB >> 4610179

Intermediates of bacteriophage MS2 assembly in vivo.

P H Bonner.   

Abstract

The in vivo process of virion assembly was studied in rifampin-treated, MS2-infected Escherichia coli during late times of infection-after 18 min postinfection. Differential sucrose gradient sedimentation of infected-cell lysates taken at various times after radioactive labeling indicated a definite temporal order of appearance of phage-specific protein in assembly-related structures. Labeled MS2 protein appears first as a low-molecular-weight peak at the tops of gradients, then as a peak at 40S and as a large number of almost unseparable structures between 40 and 80S, and finally as 80S mature phage particles. During the chase of a short labeling period, radioactive phage protein was found to disappear from gradients in the same temporal order as it appeared; the soluble peak disappears first, followed by the 40 to 70S region. The chased label appears quantitatively in the 80S phage peak. Labeled phage RNA was found to appear first in the 40S peak, then in the structures between 40 and 70S, and finally in 80S phage particles. The order of disappearance of labeled phage RNA during a chase is the same as its appearance. Resedimentation of the 40 to 70S region indicated the presence of distinct structures at 60 and 70S and many indistinct ones between 40 and 60S. The smaller intermediates exhibit separable maturation protein-rich and coat protein-rich segments, indicating nonrandom binding of the two proteins during the initial steps of assembly. Larger, discrete intermediates appear at 60 and 70S. Treatment of the various structures with pancreatic RNase results in destruction of those from 40 through 60S; treatment of the 70S structure results in the conversion of some of it to a 45S peak, presumably the complete capsid. A small fraction of the 80S phage peak is also sensitive to RNase, resulting in a similar 45S peak. Pulse-chase experiments indicate that structures from 40 through 60S as well as the RNase-sensitive 70S structure are assembly intermediates, but that the RNase-insensitive 70S and the RNase-sensitive 80S structures are not.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4610179      PMCID: PMC355632     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Growth of bacteriophage f2 in E. coli treated with rifampicin.

Authors:  H P Fromageot; N D Zinder
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

2.  Synthesis of virus-specific proteins in Escherichia coli infected with the RNA bacteriophage MS2.

Authors:  E Viñuela; I D Algranati; S Ochoa
Journal:  Eur J Biochem       Date:  1967-03

3.  Association of bacteriophage proteins and RNA in E. coli infected with MS2.

Authors:  E Richelson; D Nathans
Journal:  Biochem Biophys Res Commun       Date:  1967-12-29       Impact factor: 3.575

4.  Mode of action of rafamycin on the RNA polymerase reaction.

Authors:  A Sippel; G Hartmann
Journal:  Biochim Biophys Acta       Date:  1968-03-18

5.  Selfassembly of defective particles of the bacteriophage fr.

Authors:  T Hohn
Journal:  Eur J Biochem       Date:  1967-09

6.  The replication of bacteriophage MS2. VI. Interaction between bacteriophage RNA and cellular components in MS2-infected Escherichia coli.

Authors:  G N Godson; R L Sinsheimer
Journal:  J Mol Biol       Date:  1967-02-14       Impact factor: 5.469

7.  A slowly sedimenting, infective form of bacteriophage R17.

Authors:  J A Steitz
Journal:  J Mol Biol       Date:  1968-05-14       Impact factor: 5.469

8.  The reconstitution of infective bacteriophage R17.

Authors:  J W Roberts; J E Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1967-10       Impact factor: 11.205

9.  Acrylamide-gel electrophorograms by mechanical fractionation: radioactive adenovirus proteins.

Authors:  J V Maizel
Journal:  Science       Date:  1966-02-25       Impact factor: 47.728

10.  Ribonucleoprotein complexes formed between bacteriophage MS2 RNA and MS2 protein in vitro.

Authors:  T Sugiyama; R R Hebert; K A Hartman
Journal:  J Mol Biol       Date:  1967-05-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.